Breathe Well Live Well
|
FDA Committee: Is Novel Anti-IL-5 Safe in Asthma?
MedPage Today In those two studies, with patients receiving reslizumab or placebo in addition to standard-of-care treatment, the asthma exacerbation frequency was decreased by at least half, with rate ratios of 0.50 (95% CI 0.37-0.67) and 0.41 (95% CI 0.28-0.59, P<0 … |
View full post on asthma – Google News
Lung Disease News |
FDA Committee Recommends Approval Of Nucala For Adult Asthma Patients
Lung Disease News An FDA advisory committee recently voted unanimously to approve Nucala for the treatment of severe asthma with eosinophilic inflammation in patients 18 and older. The committee, however, decided against the use of the therapy in adolescents aged … GSK's new asthma biologic gains FDA panel backing |
View full post on asthma – Google News
 Medscape |
EU Committee Rejects Budesonide/Salmeterol Combo for Asthma
Medscape The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a negative recommendation on the marketing application for anti-asthma combination medication budesonide/salmeterol (Labazenit, … |
View full post on asthma – Google News
 ThinkProgress |
Asthma, Baby, Asthma: House Energy Committee Eliminates Protection From Smog
ThinkProgress In other words, air pollution that triggers asthma attacks and respiratory diseases would only be reduced if the polluters could afford it. In addition, the bill would require endless study of other possible pollution reduction requirements, … |
View full post on asthma – Google News
|
Asthma Foundation supports Ministerial Committee on Poverty
Scoop.co.nz (press release) For example, Waikato DHB statistics for 2000-2006 estimate that 97% of admissions to hospital for asthma were avoidable – about half of were children aged 0-14. Prevention is the key to keeping our children out of hospital. … |
View full post on asthma – Google News
A newly formed advisory committee will develop and coordinate a strategic federal research agenda on environmental and genetic factors related to breast cancer.
The 19-member Interagency Breast Cancer and Environmental Research Coordinating
Committee (IBCERCC) was established by the National Institute of Environmental
Health Sciences (NIEHS), in collaboration with the National Cancer Institute
(NCI), to review all breast cancer research efforts conducted or supported
by federal agencies.
View full post on National Institutes of Health (NIH) News Releases
The National Institutes of Health Advisory Committee on Research on Women’s Health announces the appointment of five new members: Francisco Garcia, M.D., M.P.H., Ronda S. Henry-Tillman, M.D., F.A.C.S., Karen E. Kim, M.D., Claire Pomeroy, M.D., and Paul F. Terranova, Ph.D.
View full post on National Institutes of Health (NIH) News Releases